Condition
Emphysema clinical trials and research
As of November 12, 2026, Find a Trial lists 23 Emphysema clinical trials that are recruiting, at sites in 14 countries (most in United States (8), Netherlands (5), Austria (3)). 1 was first registered in the last 30 days. By phase: Early Phase 1 (1), Phase 4 (1). The most active sponsors are Apreo Health, Inc. (2), China-Japan Friendship Hospital (2), Pulmair Medical, Inc. (2). There are also 23 NIH-funded research projects on Emphysema, with $17.1 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 23Clinical trials
- 23NIH research projects
- 1New in 30 days
- 14Countries
Newest Emphysema clinical trials
All recruiting trials (23)
-
Xenon MRI test for lung changes after Apreo BREATHE airway treatment in emphysema
This study tests whether hyperpolarized Xenon MRI can show regional ventilation and gas-exchange changes after the Apreo BREATHE airway scaffolds in people with emphysema and air trapping.
-
Prediction score for death or lung transplant in emphysema caused by alpha-1 antitrypsin deficiency
This study tests a new prediction tool to identify people with emphysema due to alpha-1-antitrypsin deficiency who are at high risk of death or needing a lung transplant.
-
Testing CE1226 doses to slow lung disease in adults with alpha-1 antitrypsin deficiency
This trial tests two active doses of CE1226 to see if they slow lung density decline in adults with AAT deficiency and emphysema over 3 years compared with the standard 60 mg/kg dose.
-
Implant to help adults with severe emphysema
This study will test whether an implantable artificial bronchus can improve breathing and safety in adults with severe COPD/emphysema.
-
Endobronchial silicone valve to help breathing in people with severe emphysema
This trial tests whether placing a silicone valve in the airways of one lung region can improve breathing for people with severe emphysema when added to usual care.
-
Implantable Artificial Bronchus 50 Flex for adults with severe emphysema
This tests a small implant called the IAB 50 Flex to see if it is safe and helps adults with severe COPD or emphysema breathe and move more easily.
-
Multidisciplinary sarcopenia clinic to diagnose and treat muscle loss from COPD
This project will try a multidisciplinary sarcopenia clinic to see if it improves muscle mass, function, and overall health for COPD patients with CT-confirmed muscle loss after a hospitalization.
-
Bronchoscopic release of trapped air in hyperinflated emphysematous lungs
This trial tests if placing permanent Apreo BREATHE airway scaffold implants by bronchoscopy, together with usual medical care, helps adults with COPD and emphysema who remain short of breath from lung hyperinflation.
-
Lung cancer screening program for patients with COPD or emphysema
This study is testing if regular lung cancer screenings can help people with COPD or emphysema catch lung cancer earlier and live longer.
-
Endobronchial thermal liquid ablation for treating emphysema
This study is testing a new treatment called endobronchial thermal liquid ablation to see if it can safely help people with severe emphysema breathe better and improve their quality of life.
-
Assessing lung health using ultrasound in emphysema patients
This study is testing if lung ultrasound can help doctors better understand lung health in people with emphysema compared to healthy individuals and those with lung cancer.
-
Using breath analysis to identify multiple lung diseases
This study is testing if analyzing breath samples can help identify different lung diseases like lung cancer and COPD in a large group of 10,000 people.
-
Evaluating a new valve for lung volume reduction in COPD patients
This study is testing a new valve to see if it can safely help people with COPD and emphysema breathe better and feel more active after a lung procedure.
-
Observational surveillance of Zephyr Valve use for severe emphysema in Japan
This study is testing the use of the Zephyr Valve in 140 patients with severe emphysema in Japan to see how it affects their lung function, exercise ability, and quality of life over a year.
-
Examining muscle function changes before and after endobronchial valve treatment for emphysema
This study is testing how a specific lung treatment for severe emphysema affects muscle function in patients to see if it helps them feel better and move more easily.
-
Using voice and breathing tests to detect emphysema in COPD patients
This study is testing whether voice and breathing tests can help find out how severe emphysema is in people with COPD.
-
Understanding MMP12 levels in patients with emphysema
This study is trying to see if measuring a specific protein in the sputum and blood of people with emphysema can help understand their lung condition and find better treatments.
-
Comparing lung surgery and bronchoscopic treatment for severe emphysema
This study is testing whether lung surgery or a less invasive bronchoscopic treatment works better for people with severe emphysema.
-
Registry to evaluate the Spiration Valve System for severe emphysema
This study is testing how well the Spiration Valve System works and how safe it is for adults with severe emphysema over three years after they receive the treatment.
-
Long-term follow-up for patients with COPD in Kingston
This study is trying to create a better way to follow up with people in Kingston who have COPD by collecting important health information to improve their care and treatment.
-
Evaluating airflow limitation in COPD, emphysema, and asthma overlap
This study is trying to see how airflow problems in chronic smokers with COPD, emphysema, and asthma overlap are caused by different parts of the lungs and how they relate to lung health.
-
A patient registry for COPD research
This study is gathering health information from over 75,000 people with COPD to help find better treatments and a cure for the disease.
-
Registry for patients with emphysema and COPD
This study is collecting information from people with emphysema and COPD to help researchers learn more about these lung diseases and improve future treatments.
NIH-funded research (23)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Precision phenotyping of emphysema in the elderly: a study in diverse adults
Researchers will look at CT scans and lung tests in older adults to understand different forms of emphysema and how they relate to health outcomes.
-
Lithium as a potential disease-modifying treatment for emphysema using a precision approach
A low-dose lithium approach is being studied to slow or modify emphysema in smokers who have COPD.
-
Imaging and multi-omics to find subtypes of emphysema in COPD
This project looks for molecular subtypes of emphysema in COPD by combining imaging with blood and tissue data to improve understanding and treatment options.
-
Precision phenotyping of emphysema in the elderly: the MESA Lung Study
Aging adults with or without COPD-related symptoms may benefit from a new study that maps subtypes of emphysema on CT scans to better predict health risks.
-
E-cigarette use and emphysema risk in young adults (VapeScan)
A study to understand whether vaping or traditional cigarettes cause early lung damage in young adults.
-
Loss of lung blood-vessel stem cells that may speed lung aging and raise emphysema risk
Researchers will look at how losing a type of lung blood-vessel progenitor cell may make lungs age faster and increase emphysema risk in adults.
-
Immune cells blocking lung repair stem cells in emphysema
This project looks at how immune cells in the lungs may stop repair stem cells after viral infections in people with emphysema.
-
CD55, a lung-protective protein, and how it may prevent smoke-related lung damage
This project tests whether the protective protein CD55 can stop cigarette smoke from harming lung repair cells and slow emphysema in smokers and people with early COPD.
-
Understanding How Smoking Causes Different Types of Lung Damage
This research helps us understand why cigarette smoking can lead to different serious lung conditions like emphysema or lung scarring.
-
Finding molecular types of emphysema using CT scans and blood tests
This project uses CT lung images plus blood and lung-tissue tests to find different molecular types of emphysema in people with COPD.
-
Natural inflammation‑resolving molecules and emphysema
This project looks at whether higher blood levels of natural inflammation‑resolving molecules are linked to better breathing and less lung damage in people with emphysema.
-
MIF Genes and Therapies for Emphysema
This grant explores how a gene called MIF affects emphysema in COPD and tests ways to restore MIF to prevent severe lung infections.
-
How immune cells affect lung stem cells in emphysema
This study is looking at how certain immune cells in the lungs affect the healing stem cells in people with emphysema, aiming to find new ways to help improve lung health and prevent flare-ups.
-
Understanding how loss of certain lung cells affects aging and emphysema risk
This study is looking at how certain cells in the lungs, called mesenchymal vascular progenitors, change as we age and how their loss might lead to lung problems like emphysema, especially in people who smoke, with the hope of finding new ways to help improve lung health for older adults.
-
Investigating how MIF and CD74 contribute to emphysema development
This study is looking at how a protein called MIF might help protect lung cells from damage caused by smoking, with the goal of finding new ways to prevent or treat emphysema for people who are affected by this lung condition.
-
Understanding combined pulmonary fibrosis and emphysema using advanced imaging techniques
This study is looking at how to better understand and diagnose combined pulmonary fibrosis and emphysema (CPFE) by using advanced imaging techniques, so that patients can receive more accurate diagnoses and personalized treatment plans.
-
Investigating how specialized molecules help reduce inflammation in emphysema
This study is looking at how certain natural substances in the body can help reduce inflammation and improve lung health in people with emphysema, and it will track how these substances affect breathing and inflammation over time.
-
Using doxycycline to slow emphysema in people living with HIV
The DEPTH trial is testing whether the antibiotic doxycycline can help slow down emphysema in people living with HIV, and if you join, you'll either get doxycycline or a placebo for about a year and a half while we check how well your lungs are working.
-
Identifying molecular subtypes of emphysema using imaging and multi-omics data
This study is looking at different types of emphysema to better understand the disease and find new ways to treat it, and it involves patients sharing blood and lung tissue samples along with imaging tests.
-
Using doxycycline to slow emphysema in people with HIV
The DEPTH trial is looking at whether the antibiotic doxycycline can help slow down emphysema in people with well-controlled HIV who are current or former smokers, and you'll either get doxycycline or a placebo for 72 weeks to see how it affects your lung function.
-
Investigating B cells in patients with emphysema-predominant COPD
This study is looking at how a type of immune cell called B cells acts in people with emphysema, a form of chronic lung disease, to see how these changes might be linked to lung damage, and it involves analyzing samples from patients to better understand what's happening in their lungs.
-
Investigating how a protein protects lung cells from damage caused by cigarette smoke
This study is looking at how cigarette smoke harms lung cells and whether a protein called CD55 can help protect them, with the goal of finding ways to prevent lung damage in smokers and identify those at risk for conditions like emphysema and COPD.
-
Understanding how emphysema progresses in patients
This study is looking at how emphysema, a serious lung condition, gets worse over time, using special scans to help doctors create more tailored treatment plans for patients based on their unique situation.
Related topics
Quick answers
How many Emphysema clinical trials are recruiting right now?
23, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 14 countries. The most sites are in United States (8 trials), Netherlands (5 trials), Austria (3 trials), China (3 trials), Denmark (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Early Phase 1: 1, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.